Short Interest in Gyrodyne LLC (NASDAQ:GYRO) Decreases By 40.0%

Gyrodyne LLC (NASDAQ:GYRO) was the recipient of a significant decline in short interest during the month of June. As of June 30th, there was short interest totalling 1,800 shares, a decline of 40.0% from the May 30th total of 3,000 shares. Approximately 0.1% of the shares of the company are sold short. Based on an average daily trading volume, of 700 shares, the days-to-cover ratio is presently 2.6 days.

A hedge fund recently raised its stake in Gyrodyne stock. Gabelli Funds LLC boosted its holdings in shares of Gyrodyne LLC (NASDAQ:GYRO) by 15.9% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,164 shares of the real estate investment trust’s stock after buying an additional 6,049 shares during the quarter. Gabelli Funds LLC owned approximately 2.98% of Gyrodyne worth $795,000 at the end of the most recent reporting period. 33.35% of the stock is currently owned by hedge funds and other institutional investors.

NASDAQ GYRO traded up $0.17 during trading on Friday, reaching $18.61. 105 shares of the company’s stock were exchanged, compared to its average volume of 175. The firm’s 50 day simple moving average is $18.85. The company has a quick ratio of 3.62, a current ratio of 3.62 and a debt-to-equity ratio of 0.08. Gyrodyne has a fifty-two week low of $16.76 and a fifty-two week high of $21.16.

About Gyrodyne

Gyrodyne, LLC. owns, leases and manages diverse commercial properties. The firm is distinguished by its service-oriented philosophy toward property ownership and management. Gyrodyne has grown from a largely Long Island player during the past into a diversified East Coast presence with an emphasis on medical office product.

Recommended Story: Net Margin

Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.